Prinomastat | m-entrepreneurship.com

Product Name :
Prinomastat

Search keywords :
Prinomastat

drugId :
null

Target Vo:
Matrix metalloproteinase

Target Vo Short Name :
MMPs

Moa_Name:
Matrix metalloproteinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Chengdu Zenitar Biomedical Technology Co Ltd

Active Indication_Name:
Lymphoma, Large B-Cell, Diffuse

In Active Indication_Name:
Lung Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ki-67 Antibody
BNIP3 Antibody
GFP Antibody: GFP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to GFP. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of .

Author: Betaine hydrochloride

Related Posts